Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-008397
Filing Date
2017-09-13
Accepted
2017-09-13 09:08:04
Documents
34
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 PEAK PHARMACEUTICALS, INC. 10-Q peak_10q-17234.htm 10-Q 449705
2 SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_31-1.htm EX-31.1 16738
3 SECTION 302 CERTIFICATION UNDER THE SARBANES-OXLEY ACT OF 2002 OF THE PRINCIPAL exhibit_31-2.htm EX-31.2 16631
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit_32-1.htm EX-32.1 8402
5 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit_32-2.htm EX-32.2 9036
  Complete submission text file 0001654954-17-008397.txt   1345579

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pkph-20170331.xml EX-101.INS 126285
7 XBRL TAXONOMY EXTENSION SCHEMA pkph-20170331.xsd EX-101.SCH 13140
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pkph-20170331_cal.xml EX-101.CAL 20013
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pkph-20170331_def.xml EX-101.DEF 27255
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pkph-20170331_lab.xml EX-101.LAB 106936
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pkph-20170331_pre.xml EX-101.PRE 79795
Mailing Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260
Business Address 14201 N. HAYDEN ROAD, SUITE A-1 SCOTTSDALE AZ 85260 480.659.6404
PEAK PHARMACEUTICALS, INC. (Filer) CIK: 0001452804 (see all company filings)

EIN.: 261973257 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-53855 | Film No.: 171082320
SIC: 2834 Pharmaceutical Preparations